TELA Bio (TELA) Total Non-Current Liabilities (2018 - 2026)

TELA Bio has reported Total Non-Current Liabilities for 9 years, with the latest figure at $73.7 million in Q1 2026.

• For the quarter ending Q1 2026, Total Non-Current Liabilities rose 27.48% year-over-year to $73.7 million; the trailing twelve-month figure through Mar 2026 stood at $73.7 million (up 27.48% YoY), and the FY2025 full-year result was $73.6 million, up 29.81% from the prior year.
• Total Non-Current Liabilities for Q1 2026 stood at $73.7 million, roughly flat from $73.6 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $73.7 million in Q1 2026, with the low at $44.0 million in Q1 2022.
• Average Total Non-Current Liabilities over 5 years is $57.1 million, with a median of $55.8 million recorded in 2024.
• Year-over-year, Total Non-Current Liabilities jumped 35.11% in 2022 and declined 1.32% in 2024.
• Tracing TELA's Total Non-Current Liabilities over 5 years: stood at $52.3 million in 2022, then grew by 9.87% to $57.5 million in 2023, then decreased by 1.32% to $56.7 million in 2024, then advanced by 29.81% to $73.6 million in 2025, then rose by 0.1% to $73.7 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $73.7 million (Q1 2026), $73.6 million (Q4 2025), and $58.5 million (Q3 2025), per Business Quant data.

Peer Comparison